SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-061662
Filing Date
2014-10-17
Accepted
2014-10-17 14:00:58
Documents
7
Period of Report
2014-12-11
Effectiveness Date
2014-10-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A v391511_def14a.htm DEF 14A 124231
2 GRAPHIC image_001.gif GRAPHIC 93
3 GRAPHIC image_001.jpg GRAPHIC 723
4 GRAPHIC image_002.jpg GRAPHIC 723
5 GRAPHIC image_003.jpg GRAPHIC 717
6 GRAPHIC logo_001.jpg GRAPHIC 717
7 GRAPHIC tlogo.jpg GRAPHIC 21743
  Complete submission text file 0001144204-14-061662.txt   160287
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20713 | Film No.: 141161604
SIC: 2836 Biological Products, (No Diagnostic Substances)